These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29579038)

  • 21. The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.
    Mupfasoni D; Montresor A; Mikhailov A; King J
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005202. PubMed ID: 27992424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa.
    Won KY; Robinson K; Hamlin KL; Tufa J; Seespesara M; Wiegand RE; Gass K; Kubofcik J; Nutman TB; Lammie PJ; Fuimaono S
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006347. PubMed ID: 29522520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
    Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
    Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
    Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National mapping of soil-transmitted helminth and schistosome infections in Ethiopia.
    Leta GT; Mekete K; Wuletaw Y; Gebretsadik A; Sime H; Mekasha S; Woyessa A; Shafi O; Vercruysse J; Grimes JET; Gardiner I; French M; Levecke B; Drake L; Harrison W; Fenwick A
    Parasit Vectors; 2020 Sep; 13(1):437. PubMed ID: 32873333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphatic filariasis in western Ethiopia with special emphasis on prevalence of Wuchereria bancrofti antigenaemia in and around onchocerciasis endemic areas.
    Shiferaw W; Kebede T; Graves PM; Golasa L; Gebre T; Mosher AW; Tadesse A; Sime H; Lambiyo T; Panicker KN; Richards FO; Hailu A
    Trans R Soc Trop Med Hyg; 2012 Feb; 106(2):117-27. PubMed ID: 22154976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of treatment impact on lymphatic filariasis in 13 districts of Benin: progress toward elimination in nine districts despite persistence of transmission in some areas.
    Boko-Collins PM; Ogouyemi-Hounto A; Adjinacou-Badou EG; Gbaguidi-Saizonou L; Dossa NI; Dare A; Ibikounle M; Zoerhoff KL; Cohn DA; Batcho W
    Parasit Vectors; 2019 May; 12(1):276. PubMed ID: 31146779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
    Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
    Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon.
    Beng AA; Esum ME; Deribe K; Njouendou AJ; Ndongmo PWC; Abong RA; Fru J; Fombad FF; Nchanji GT; Amambo G; Gandjui NTV; Biholong B; Nko'Ayissi G; Mbia P; Akame J; Enyong PI; Reid SD; Tougoue JJ; Zhang Y; Wanji S
    BMC Infect Dis; 2020 Apr; 20(1):284. PubMed ID: 32299374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated mapping of lymphatic filariasis and podoconiosis: lessons learnt from Ethiopia.
    Sime H; Deribe K; Assefa A; Newport MJ; Enquselassie F; Gebretsadik A; Kebede A; Hailu A; Shafi O; Aseffa A; Reithinger R; Brooker SJ; Pullan RL; Cano J; Meribo K; Pavluck A; Bockarie MJ; Rebollo MP; Davey G
    Parasit Vectors; 2014 Aug; 7():397. PubMed ID: 25164687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urban lymphatic filariasis in the city of Tanga, Tanzania, after seven rounds of mass drug administration.
    Mwakitalu ME; Malecela MN; Pedersen EM; Mosha FW; Simonsen PE
    Acta Trop; 2013 Dec; 128(3):692-700. PubMed ID: 24135628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.
    Chesnais CB; Awaca-Uvon NP; Bolay FK; Boussinesq M; Fischer PU; Gankpala L; Meite A; Missamou F; Pion SD; Weil GJ
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005703. PubMed ID: 28892473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014.
    Graves PM; Sheridan S; Fuimaono S; Lau CL
    Parasit Vectors; 2020 Mar; 13(1):125. PubMed ID: 32164780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
    Lupenza ET; Gasarasi DB; Minzi OM
    PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination.
    Nana-Djeunga HC; Tchatchueng-Mbougua JB; Bopda J; Mbickmen-Tchana S; Elong-Kana N; Nnomzo'o E; Akame J; Tarini A; Zhang Y; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2015; 9(9):e0004001. PubMed ID: 26353087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and factors associated with transmission of lymphatic filariasis in South Sudan: a cross-sectional quantitative study.
    Senkwe MN; Berta KK; Logora SMY; Sube J; Bidali A; Abe A; Onyeze A; Pita J; Rumunu J; Maleghemi S; Ndenzako F; Olu OO
    Pan Afr Med J; 2022; 42(Suppl 1):9. PubMed ID: 36158938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of Integrated Transmission Assessment Surveys for Lymphatic Filariasis and Malaria in Haiti, 2017-2022.
    Désir L; Hamre KES; Beau De Rochars VM; Lemoine JF; Telfort MA; Noland GS
    Am J Trop Med Hyg; 2024 Sep; 111(3_Suppl):81-88. PubMed ID: 38917782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
    Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya.
    Njenga SM; Kanyi HM; Mutungi FM; Okoyo C; Matendechero HS; Pullan RL; Halliday KE; Brooker SJ; Wamae CN; Onsongo JK; Won KY
    Parasit Vectors; 2017 Feb; 10(1):99. PubMed ID: 28228160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-Reactivity of Filariais ICT Cards in Areas of Contrasting Endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for Shrinking of the Lymphatic Filariasis Map in the Central African Region.
    Wanji S; Amvongo-Adjia N; Koudou B; Njouendou AJ; Chounna Ndongmo PW; Kengne-Ouafo JA; Datchoua-Poutcheu FR; Fovennso BA; Tayong DB; Fombad FF; Fischer PU; Enyong PI; Bockarie M
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004184. PubMed ID: 26544042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.